<?xml version="1.0"?>
  <rss version="2.0">
    <channel>
      <title>Ibandronate News : GoldBamboo.com</title>
      <link>http://goldbamboo.com/</link>
      <description>Ibandronate News from GoldBamboo.com</description>
      <language>en-us</language>
      <copyright>&amp;copy; 2005, Gold Bamboo LLC, All Rights Reserved</copyright>
      
	<item>
        <title>Vitamin D may prevent alcohol-related bone loss</title>
        <link>http://goldbamboo.com/news-a218122.html</link>
        <description>NEW YORK (Reuters Health) - Numerous cell, animal and human studies have shown that heavy drinking leads to bone loss. New research conducted in rats now suggests that vitamin D or the anti-osteoporosis drug Boniva (ibandronate) can prevent alcohol-related bone loss caused by regular binge drinking.</description>
		 <pubDate>Tue, 30 Jan 2007 04:39 EST</pubDate>
	</item>
	<item>
        <title>Vitamin D Or Boniva® (ibandronate) Reduces Bone Loss From Binge Drinking</title>
        <link>http://goldbamboo.com/news-a213523.html</link>
        <description>It appears that alcohol-induced bone loss resulting from excessive binge-alcohol drinking can be prevented by vitamin D or the anti-osteoporosis drug Boniva® (ibandronate), a Loyola University Health System study shows. [click link for full article]</description>
		 <pubDate>Mon, 01 Jan 2007 08:00 EST</pubDate>
	</item>
	<item>
        <title>Higher Persistency Rates Seen With FOSAMAX® Once Weekly Therapies Compared To Other Weekly And Monthly Oral Bisphosphonates</title>
        <link>http://goldbamboo.com/news-a199810.html</link>
        <description>Higher persistency rates were seen among osteoporosis patients taking FOSAMAX® Once Weekly (alendronate) therapies than were seen among patients taking ibandronate once monthly or once weekly risedronate therapies, according to results from two new outcomes studies conducted by Merck &amp; Co., Inc. that compared persistency rates of weekly versus monthly oral bisphosophate dosing frequency. [click link for full article]</description>
		 <pubDate>Mon, 25 Sep 2006 07:00 EST</pubDate>
	</item>
	<item>
        <title>Quarterly injections counter osteoporosis</title>
        <link>http://goldbamboo.com/news-a185373.html</link>
        <description> NEW YORK (Reuters Health) - The anti-osteoporosis drug   ibandronate, known by the brand name Boniva or Bonviva, can be   given by injection every 2 or 3 months, and may be more   effective than a daily pill, according to an international   team.</description>
		 <pubDate>Tue, 20 Jun 2006 04:27 EST</pubDate>
	</item>
	<item>
        <title>Intravenous Bisphosphonate Treatment For Postmenopausal Osteoporosis</title>
        <link>http://goldbamboo.com/news-a136875.html</link>
        <description>Bisphosphonates, such as ibandronate, have been shown to be effective in reducing the risk of fracture related to postmenopausal osteoporosis when taken orally on a daily basis... click link for more info.</description>
		 <pubDate>Fri, 01 Jul 2005 06:00 EST</pubDate>
	</item>
	

    </channel>
  </rss>
